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Abstract
Cellular differentiation entails reprogramming of the transcriptome from a pluripotent to a unipotent fate. This process was
suggested to coincide with a global increase of repressive heterochromatin, which results in a reduction of transcriptional
plasticity and potential. Here we report the dynamics of the transcriptome and an abundant heterochromatic histone
modification, dimethylation of histone H3 at lysine 9 (H3K9me2), during neuronal differentiation of embryonic stem cells. In
contrast to the prevailing model, we find H3K9me2 to occupy over 50% of chromosomal regions already in stem cells.
Marked are most genomic regions that are devoid of transcription and a subgroup of histone modifications. Importantly, no
global increase occurs during differentiation, but discrete local changes of H3K9me2 particularly at genic regions can be
detected. Mirroring the cell fate change, many genes show altered expression upon differentiation. Quantitative sequencing
of transcripts demonstrates however that the total number of active genes is equal between stem cells and several tested
differentiated cell types. Together, these findings reveal high prevalence of a heterochromatic mark in stem cells and
challenge the model of low abundance of epigenetic repression and resulting global basal level transcription in stem cells.
This suggests that cellular differentiation entails local rather than global changes in epigenetic repression and
transcriptional activity.
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Introduction
Resetting of the transcriptional program is the key driver for
cell type specification during organismal development [1,2].
While embryonic stem (ES) cells bear the fascinating ability to
acquire very diverse fates, derived somatic stages are usually
irreversible under physiological conditions. This unidirectionality
has been suggested to depend in part on epigenetic repression of
lineage unrelated genes [3,4]. Accordingly, ES cell plasticity was
suggested to rely on a low prevalence of heterochromatin and
coinciding promiscuous low-level expression of many genes in
stem cells [5–11]. In line with this model, distinct changes in
nuclear staining had previously been observed by electron
microscopy during cellular differentiation [12,13]. Further, a
subset of promoters was shown to become DNA methylated [14–
16] and the repressive histone modifications H3K27me3 and
H3K9me3 were reported to locally expand in differentiated cells
[9].
Here, we set out to test the model of widespread heterochro-
matinization via monitoring of the differentiation-coupled
dynamics of H3K9me2, a repressive epigenetic modification,
which appears to be the most abundant heterochromatic
modification and has recently been reported to cover large
domains in differentiated cells [17]. Unexpectedly, we found
that H3K9me2 is not only highly abundant in terminally
differentiated cells, but already occupies large parts of the
genome in pluripotent stem cells. In this cellular state,
H3K9me2 occupies most genomic regions devoid of transcrip-
tion and certain histone modifications. While our analysis
revealed discrete local changes particularly at gene bodies, we
observed little global increase in H3K9me2 during differentia-
tion. This unexpected finding motivated us to revisit the model
of promiscuous low-level gene expression in undifferentiated
cells by quantitative RNA sequencing. Remarkably, we found
the actual number of low-level expressed genes, postulated
hallmarks of stem cells to be equal between both developmental
states. Together, our findings challenge the model of promis-
cuous basal gene expression as a distinct property of pluripo-
tency and a widespread increase of heterochromatin during
cellular differentiation.
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H3K9me2 is nearly invariant and only displays distinct
local changes between developmental stages
To asses differentiation associated dynamics of the repressive
histone modification H3K9me2 we made use of a highly pure and
robust murine in vitro neurogenesis model [18], which we previously
used to profile histone and DNA methylation [14]. Here, we
generated profiles for H3K9me2 in pluripotent embryonic stem
cells and derived terminally differentiated pyramidal neurons. We
made use of custom tiling arrays covering 10% of the mouse
genome including all well-annotated promoters, several large multi-
gene loci and the complete chromosome 19 (see Figure S1 and Text
S1). The chromosomal profiles for H3K9me2 revealed domains of
enrichments that upon visual inspection were highly comparable
between stem cells and the neuronal state (Figure 1A), which is
furthersupportedbyahighoverallpair-wisecorrelation(Figure 1B).
Despite this overall similarity we noticed confined regional
differences (Figure 1A), a finding which is consistent with the fact
that biological replicates of H3K9me2 are more similar than the
patterns between cell states (Figure 1B). We also included in our
comparison a recently published dataset for H3K9me2 in a distinct
ES cell line [17], which shows high correlation to our ES cell
datasets despite different experimental conditions (Figure S2). Of
note, analysis of the H3K9me2 dataset from Wen et al. [17]
revealed that chromosome 19 behaves similar to the other
chromosomes (Figure S3), suggesting that our results can be
extrapolated to the entire genome. Together this demonstrates that
our H3K9me2 data are reproducible and of high resolution, yet
overall patterns appear to be highly similar between a pluripotent
and a terminally differentiated state. Visual inspection suggests that
H3K9me2 covers large domains in both ES cells and neurons
(Figure 1A). To quantitatively define the actual location and sizes of
domains we applied a Hidden-Markov-Model (HMM) analysis to
themicroarraydata.Thisunsupervisedstatisticalmethod isawidely
accepted approach for unbiased data segmentation in epigenome
analysis [19,20]. The HMM analysis not only agreed with and
statistically corroborated the visual impression of the raw data, but
also yielded robust results under variable settings (Figure S4). It
revealed that over 50% of chromosome 19 is covered by H3K9me2
in ES cells (Figure 1C). Using the same approach for the H3K9me2
data in the ES cell-derived terminally differentiated neurons, we
detected a modest yet reproducible 5% increase of genomic regions
covered by H3K9me2 (Figure 1C). We conclude that global
coverage and size of H3K9me2 domains is nearly identical between
ES cells and derived post-mitotic pyramidal neurons. In line with
this finding we do not detect a significant change in global
H3K9me2 levels by Western blot detection (Figure 1D). Moreover,
H3K9me2 domain features of ES cells and neurons show similar
size distribution and median length (Figure S4). Further analysis
revealed that changes in H3K9me2 between the two examined
cellular states are rare; 88% of H3K9me2 occupied regions in ES
cells are also occupied in neurons (Figure 1F). Notably, regions that
change in H3K9me2 state tend to be small and are below the
average size of invariant domains (Figure S5). Consistent with the
overallincreaseof5%inH3K9me2coverageduringdifferentiation,
regions which gain H3K9me2 are more frequent and of larger size
than regions showing a loss of the mark (Figure S5 and Figure S6).
Interestingly, most of the larger regions (.10 kb) that gain
H3K9me2 are located within genes, starting downstream of the
promoter region (Figure 2A and Figure S5). These global findings
are fully reproducible in single gene controls (Figure 2B) and
consistent with a focused comparison of only genic regions
(Figure 2C). Importantly, this shows that our experimental and
data analysis approach is indeed highly sensitive to detect
differences if they do occur. Interestingly, many genes that acquire
H3K9me2 show slightly reduced expression in many cases, while
others increase expression upon gain of the modification (Figure 2D
and Figure S5). This suggests that the gain of H3K9me2, while
highly selective for gene bodies, cannot simply be explained by the
silencing of gene activity.
H3K9me2 and H3K27me3 are mutually exclusive
Given the high prevalence of H3K9me2, we next asked how its
presence relates to a distinct repressive chromatin modification,
namely trimethylation of H3K27 (H3K27me3). This mark is set
by the Polycomb pathway and often occurs in domains of several
kilobases [9,21,22]. We find that both heterochromatic histone
modifications occur mutually exclusive even when in direct
neighborhood as illustrated by the sharp boundaries of the
H3K9me2 signal next to H3K27me3 peaks (Figure 3A, 3B and
3C). This is consistent with a previous study in human embryonal
carcinoma cells that was limited to promoters [23].
H3K9me2 is largely exclusive with active chromatin
We further related H3K9me2 occupancy to regions with
transcriptional activity or presence of the active modification
H3K4me2. Active regions are mutually exclusive with H3K9me2
in ES cells but surprisingly to a lesser extent in neurons (Figure 3D).
The compatibility of H3K9me2 and gene expression in neurons is
however limited to gene bodies and does not occur in the
promoters of expressed genes, consistent with the former regions
gaining H3K9me2 during differentiation (Figure 2A and Figure
S7). We find the majority of H3K4me2 regions to be mutually
exclusive with H3K9me2 in stem cells (Figure 3D). In neurons, a
small number of regions become co-occupied, again most of these
being within transcribed genes (Figure 3D). Importantly, an HMM
independent analysis confirms that regions with high H3K9me2
enrichment do not overlap with transcribed genes in stem cells, yet
a subset does in neurons (Figure 3E). We conclude that gain of
H3K9me2 during differentiation has only a minor effect on the
overall chromosomal coverage of the modification, yet it occurs
highly localized and preferentially at genic regions.
Prevalent low-level transcription is not a stem cell–
specific feature
Our finding of surprising conservation of heterochromatin
patterns in a refined model of differentiation let us to revisit the
Author Summary
Epigenetic modifications of DNA and bound histones are
major determinants of cell type–specific gene expression
patterns. A prevalent model in stem cell biology suggests
that the loss of pluripotency entails global increase in
heterochromatin and coinciding shutdown of lineage
unrelated genes. We performed analysis of both H3K9
dimethylation pattern and the global transcriptome in an
advanced murine neuronal differentiation model. In this
paradigm, we do not find evidence for a global increase in
heterochromatic H3K9 dimethylation or reduction of
transcriptome complexity as stem cells become terminally
differentiated post-mitotic neurons. This suggests that
pluripotent embryonic stem cells are not per se unique in
regards to heterochromatin abundance and transcriptional
plasticity as compared to somatic cells. Instead, focal
changes in chromatin might help to stabilize cellular states
at any developmental stage.
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RNA sequencing (RNAseq). RNAseq in ES cells and derived
neurons revealed the expected down regulation of stem cell
specific genes and induction of neuron specific genes (Figure 4A).
Further, when counting RNA molecules after gene mapping and
normalization, both cell types displayed a characteristic bimodal
distribution. This reflects a group of genes that is in a clear off state
with no detectable RNA molecules and a second peak of expressed
genes (Figure 4B). Separating these two groups of genes by a
stringent cutoff revealed that out of 359606 transcription units,
45% are expressed in ES cells. Interestingly, we identified a slightly
higher number (50%) of expressed genes in terminally differen-
tiated neurons, indicating that differentiation of stem cells is not
coinciding with a reduced number of highly expressed genes. This
agrees with a recent report that suggested that stem cells and
somatic cells do mainly differ in the number of low-level expressed
genes due to a global reduction of basal gene activity in the course
of lineage-commitment and loss of pluripotency [10]. To test this
in our in vitro differentiation system, we grouped the genes that
could not clearly be assigned to the on or off state, into a separate
class of genes expressed at low to background level (Figure 4B).
This analysis reveals that in stem cells 16% of all transcription
units show a basal expression level. Surprisingly however, the
proportion of genes expressed at such low level (14%) is very
similar in neurons. This unexpected finding prompted us to
conduct an additional RNAseq experiment in a second fully
differentiated somatic murine cell type; primary mouse embryonic
fibroblasts (MEFs). Interestingly, also fibroblasts display a similar
Figure 1. H3K9me2 covers large domains in pluripotent stem cells and derived neurons and is largely invariant between both
states. (A) H3K9me2 localization in ES cells and neurons at a representative chromosomal region. Bars above each track indicate H3K9me2 domains
determined by HMM. The red boxes highlight two regions that lose and gain H3K9me2, respectively. (B) Pair-wise correlation of H3K9me2 signal
among different samples and experiments. Biological replicates are indicated as 1 and 2. Pearson correlations of IP/Input ratios were calculated for
500 bp windows on chromosome 19 (white/yellow corresponds to higher correlations). (C) Quantification of genomic coverage of H3K9me2 in ES
cells and neurons applying a two-state HMM (i.e. ‘‘high’’ or ‘‘low’’). Shown is the percentage of chromosome 19 that is in an H3K9me2 ‘‘high’’ state (i.e.
enriched for H3K9me2) in both biological replicates. The value was normalized to the total coverage of the tiled region on the array. (D) Western blot
detection of H3K9me2 levels in ES cells and neurons (TN). (E) Venn diagram showing the overlap of H3K9me2 enriched regions between ES cells and
neurons (TN).
doi:10.1371/journal.pgen.1002090.g001
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transcription units being highly expressed and 13% being
expressed at basal levels. Hence, this qualitative similarity of
expression patterns is not specific to the neuronal subtype we
generated in vitro, but appears to be a more general property of
both undifferentiated and differentiated cells. Thus, while
transcripts expressed at low levels show little overlap between
stem cells and somatic cells (Figure S8), their numbers are
remarkably similar. Stem cells do also not show an increased
number of highly expressed genes. Based on additional analysis we
can exclude that this similarity of the transcriptional landscape is a
consequence of insufficient sampling (Figure S9). Moreover, it is
not limited to genic regions as the abundance of transcripts
generated from diverse classes of endogenous repeat is comparable
between stem cells and neurons (Figure 4C).
Discussion
Embryonic stem cells are characterized by their potential to
differentiate into any cell type of the three germ layers in the
developing embryo, while somatic cells lose this developmental
plasticity upon lineage-commitment. Despite its relevance for our
understanding of development and disease, the molecular
determinants of pluripotency are still not fully understood and
the factors responsible for this uniqueness of stem cells are actively
debated [24]. Our study of gene expression and an abundant
heterochromatin mark reveal surprising conservation of the
transcriptome and epigenome landscape between pluripotent
and unipotent cells. H3K9me2 is already highly prevalent in ES
cells, arguing that the pathways that mediate H3K9me2 are highly
active in stem cells, and serve similar functions as in somatic cells,
Figure 2. Changes in H3K9me2 during differentiation occur localized and at gene bodies. (A) H3K9me2 signal at the Kif20b locus as an
example of a locus, which gains H3K9me2 in neurons. Bars above each track indicate HMM-defined H3K9me2 domains. (B) Validation of microarray
results by single gene PCRs for a set of gene bodies that gain H3K9me2. Enrichments were normalized to Gda. Both Gda and Pcsk5 have equally high
H3K9me2 levels in both cellular states in the array data. Methylation levels of Hprt (negative control) and Oct4 (Pou5f1; positive control [39]) were
measured at the promoter. Shown are averages from 2 independent differentiation experiments. Error bars indicate standard deviation.
(C) Comparison of H3K9me2 enrichments in gene bodies in ES cells and neurons. Genes, which gain and lose H3K9me2 significantly (adjusted P-Value
,0.05) are depicted in green and orange, respectively. (D) RNAseq read counts of 10 genes that show the most significant gain of H3K9me2. Black
and white bars indicate RNA in ES cells (ES) and neurons (TN), respectively.
doi:10.1371/journal.pgen.1002090.g002
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Interestingly, the observed gain occurs very localized at gene
bodies and does not necessarily coincide with lower transcription
of the corresponding gene. The analysis of regions that acquire
H3K9me2 during differentiation further revealed a differentiation
specific coexistence of H3K9me2 and transcriptional activity,
which is not detected in the pluripotent state and which could be
involved in modulating expression in the differentiated cell.
Nevertheless, despite the subtle increase we detected, an
involvement of H3K9me2 in globally regulating cell-type specific
gene repression appears unlikely. The limited dynamics as
compared to massive transcriptome reprogramming and the
limited correlation between expression and gain of H3K9me2 at
target genes argue against H3K9me2 as being a major player in
setting up gene expression programs.
These findings disagree with a recent report that suggested
absence of large H3K9me2 domains in ES cells and found a
striking increase in differentiated cells [17]. Notably, our ES cell
profile for H3K9me2 is similar to the one generated previously
(Figure 1B and Figure S2), making data analysis a likely
Figure 3. H3K9me2 occurs mutually exclusive with expression and distinct chromatin marks. (A) Enrichment for H3K27me3 and
H3K9me2 in a representative region. (B) H3K9me2 enrichments relative to peaks of H3K27me3 illustrating the sharp boundaries between both marks.
Plotted are the moving-window averages (median) of H3K9me2 enrichments with window sizes of 500 bp (blue line) around all H3K27me3 domains
on chromosome 19 (shown in grey). (C) and (D) Venn diagram illustrating the actual overlap between H3K9me2 and H3K27me3 occupied regions (C)
and between H3K9me2, H3K4me2 occupied and active regions (D). Numbers indicate base pair coverage on chromosome 19 (in kb). Note that areas
are not drawn to scale. (E) The higher H3K9me2, the less likely a genomic region is active or contains H3K27me3 or H3K4me2. H3K9me2 enrichment
values of 500 bp windows were binned into groups of equal size. Plotted is the frequency for H3K9me2 enrichment bins to overlap with active
regions (orange), H3K27me3 occupied (gray), H3K4me2 occupied (green) and regions in either of these states (black).
doi:10.1371/journal.pgen.1002090.g003
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approach that is insensitive to variations between arrays and
which we show to lead to similar results under various parameter
settings (Figure 3 and Figure S10). As already discussed by Fillion
and van Steensel [25], the previous study relied on defined
thresholds, which can be prone to false estimation of differences
particular in the absence of biological replicates [25].
Widespread low-level expression in stem cells has previously
been reported and interpreted as a sign of pluripotency [5,6,10].
It has been speculated that this basal promiscuous activity would
poise genes for rapid induction upon receipt of differentiation
cues [5,6,10]. Using mRNA sequencing in our differentiation
paradigm does not confirm this model. We do not find evidence
of elevated transcription throughout the genome or on specific
chromosome (Figure S8; [10]). A likely explanation for these
discrepancies is that microarrays, which were used in the
previous studies, overestimate low level signal due to cross-
hybridization [26]. In the present study we utilized RNAseq,
which permits an actual counting of RNA molecules and thus
enables accurate discrimination between very low and no
expression. Notably, RNA sequencing experiments have recently
put other findings in question that relied on quantifying small
transcriptome differences detected by microarrays. For example,
recent RNAseq data challenged the presence of pervasive
intergenic transcription [26] and the existence of transcriptional
dosage compensation of the single male X chromosome [27]. In
addition to the increased sensitivity of RNAseq that can explain
the differences to previous studies, the presence of a small
fraction of differentiated cells in suboptimal conditions of stem
cell culture could similarly contribute to an overestimation of the
number of genes that are actually expressed in stem cells.
Notably, the ES cell differentiation protocol applied by us is
optimized to reduce the number of differentiated cells in the
culture [18].
Figure 4. Promiscuous low-level expression is not a distinctive feature of the pluripotent state. (A) Representative region illustrating
RNAseq data in ES cells and neurons (TN). Blue boxes indicate genes that either increase (Lrrc3, a neuron specific ion channel) or decrease (Aire,
Dnmt3l, Icosl; three ES cell specific genes) expression during differentiation, while the other genes remain constant. (B) Density distribution of
transcript abundance (measured as read counts) for all RefSeq transcripts in ES cells (green line), derived neurons (dark green line) and mouse
embryonic fibroblasts (red line). Numbers indicate percentage of expressed genes in each cell type based on a threshold of log2(read count)=5
(black dotted line). The gray area between 2 and 5 indicates the zone of low-level expression. (C) Boxplot representation of expression levels of
prominent repeat classes in ES cells and neurons (TN). Numbers below indicate how many repeat elements are included in each repeat class.
doi:10.1371/journal.pgen.1002090.g004
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heterochromatinization during cellular differentiation via a global
increase in repressive histone marks [5–9,17] and coinciding
repression of basal gene activity [5,6,10].
Our data together with previous reports on dynamics of DNA
methylation, H3K9me3 and the Polycomb pathway between
pluripotent and somatic cells [9,14,15,28–31] support a model
whereby repressive chromatin is already highly active in stem cells
and that epigenome reprogramming entails localized changes of
repressive histone modifications and DNA methylation at
regulatory regions that specify and stabilize lineage specification
and terminal differentiation [32]. It will be interesting to
determine if these local differences account for the observed
changes in nuclear morphology [33]. Notably, epigenetic repres-
sion can be overcome by the local activity of transcription factors
upon strong induction cues during normal differentiation or
artificially during generation of induced pluripotent stem cells (iPS)
[34] and might therefore safeguard rather than actively channel
development via direct transcriptome regulation.
Methods
Cell culture
Wild-type embryonic stem cells (129Sv-C57Bl/6) were cultured
and differentiated as previously described [14,35]. Fibroblasts
were isolated from wild-type embryos (C57Bl/6).
Western blot and peptide dot blot analysis
Peptide sequences can be found in Table S2. Western blot
analysis was performed with acid extracts using 1/1000 dilutions
of either anti-H3K9me2 (Abcam no. 1220) or anti-H4 (Upstate,
no. 07–108) antibodies. Blots were developed with ECL reagent
(GE Healthcare).
Chromatin-IP (ChIP)
ChIP experiments were performed as described before [14],
starting with 70 mg of chromatin and 5 mg of the following
antibodies: anti-dimethyl-H3K9 (LP Bio, no. AR-0108), anti-
dimethyl-H3K9 (Abcam no. 1220), anti-trimethyl-H3K27 (Up-
state, no. 07–449), anti-dimethyl-H3K4 (Upstate, no. 07–030).
H3K9me2 ChIP samples were amplified using the WGA2 kit
(Sigma) and hybridized to a custom tiling microarray (NimbleGen
Systems Inc., see below). H3K27me3 and H3K4me2 ChIP
libraries for Illumina sequencing were prepared with the Illumina
ChIP-Seq DNA Sample Prep Kit (Cat# IP-102-1001) according
to Illumina’s instructions and sequenced on the Genome Analyzer
II following the manufacturer’s protocols. ChIP-real time PCR
was performed using SYBR Green chemistry (ABI) and 1/40 of
ChIP or 20 ng of input chromatin per PCR reaction. Primers are
listed in Table S1.
Microarray design
H3K9me2 ChIP samples were hybridized to custom designed
microarrays representing all well-annotated promoters, several
large multi-gene loci and the complete chromosome 19 with an
average probe spacing of 100 bp and a total of 2.1 million features
(HD2.1, NimbleGen Systems Inc).
Microarray hybridization and analysis
Samplelabeling,hybridizationandarrayscanningwereperformed
by NimbleGen Systems Inc. according to standard procedures. For
analysis,rawfluorescentintensityvalueswereusedtocalculatelog2of
the bound/input ratios for each individual oligo. Subsequently, for
comparisonallarrayswerenormalizedtoamedianlog2=0andscale
normalized to have the same median absolute deviation using the
‘‘LIMMA’’ R/Bioconductor package [36,37].
RNAseq data analysis
RNA from ES cells, neurons and fibroblasts of two independent
biological replicates each was used for cDNA preparation using
oligo dT primers followed by sequencing on an Illumina GA II
analyzer. Reads were mapped to the Mus musculus transcriptome
and normalized to transcript length and sequencing library size
(for details see Text S1).
Bioinformatics
Unless otherwise stated, H3K9me2 enriched regions were
identified by HMM and H3K4me2 and H3K27me3 peaks using
MACS peak finder [38]. Active regions were defined as RefSeq
transcription units with a normalized RNAseq log2 read count
above 5 (for details see Text S1). Microarray design, hybridization
and analysis, ChIPseq and RNAseq analysis and additional
references are described in Text S1.
Datasets
Microarray and deep sequencing data were deposited at NCBI’s
Gene Expression Omnibus and are accessible through GEO Series
accession number GSE27866 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE27866).
Supporting Information
Figure S1 Specificity of H3K9me2 antibodies used in this study.
Indicated amounts of either modified or unmodified H3 and H4
peptides (H3 residues 1–20, 19–38 and 25–45, H4 residues 12–31)
were spotted onto polyvinylidene difluoride membranes (GE) and
probed with (A) anti-dimethyl-H3K9 (LP Bio, no. AR-0108) or (B)
anti-dimethyl-H3K9 (Abcam no. 1220) at 1:1000 dilution each.
Both antibodies are highly specific towards H3K9me2.
(TIF)
Figure S2 High similarity of ES cell H3K9me2 datasets.
(A) Comparison of our H3K9me2 enrichment profiles in ES cells
to a previously generated ES cell profile (Wen et al., 2009). (B) Venn
diagram illustrating the overlap of H3K9me2-occupied regions
between the two ES cell datasets from (A) (defined by an HMM
approach). The overlap agrees with the high correlation for this
previously generated ES cell dataset with our two ES cell replicates
(Pearson correlation of 0.73 and 0.74, on 500 bp windows).
(TIF)
Figure S3 H3K9me2 enrichments on chromosome 19 are
representative of the entire genome. (A) H3K9me2 enrichments
in ES cells from a previously generated dataset (Wen et al., 2009).
The boxplots show H3K9me2 enrichment values for all probes
separated by chromosome, with chromosome 19 highlighted in
blue. (B) H3K9me2 enrichments per 900 bp promoter windows
(defined in Mohn et al., 2008) in ES cells. The boxplots represent
average enrichments at promoters separated by chromosome with
chromosome 19 highlighted in blue.
(TIF)
Figure S4 H3K9me2 enriched regions are robustly identified
independent of HMM parameters and H3K9me2 domain size is
highly similar in ES cells and neurons. (A) Shown is the
comparison of H3K9me2 enrichments in ES cells and neurons
using a 3 state HMM to define non-occupied (low), intermediately
and highly occupied domains (top). Importantly, the state specific
HMM distribution parameters (mean and variance of H3K9me2
enrichment) are very similar between ES cells and neurons
H3K9me2 and Transcription during Differentiation
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domains in the high state does not change between ES cells and
neurons (TN). However, we detect an overall increase of the
intermediate state of around 10%. (B) H3K9me2 domains were
defined by HMM (see methods). While numbers of domains on
chromosome 19 increase from 1618 to 1914 from ES cells to
neurons, their domain size distribution is very similar. This was
also seen using alternative domain definition methods (data not
shown).
(TIF)
Figure S5 Regions that lose are smaller than regions that gain
H3K9me2 during differentiation and gaining regions often
overlap with gene bodies. (A and B) Histograms displaying the
size distributions of regions that lose (A) and gain (B) H3K9me2
during neuronal differentiation. Adjacent 500 bp windows being
in a low HMM state in both ES cell replicates and in a high HMM
state in the neuron replicates were grouped into H3K9me2 losing
and gaining regions, respectively. (C) Pie chart illustrating the
percentage of large (.10kb) H3K9me2 gaining regions within
(grey) and outside (white) of genes (left). This overlap is
significantly higher than for all regions that have no H3K9me2
in ES cells, i.e. which are in a HMM low state in both replicates
(right). (D) Boxplot showing expression levels of all genes (n=138,
adjusted P-value ,0.05) that gain H3K9me2 in neurons. Note
that the median expression does not change significantly between
ES cells and neurons (TN), indicating that there is no global trend
towards either up- or down-regulation upon accumulation of
H3K9me2 in the gene bodies of these genes.
(TIF)
Figure S6 Regions losing H3K9me2 during differentiation are
close to background. (A–C) Shown are representative genomic
regions that significantly lose H3K9me2 as defined by HMM
analysis. (D) ChIP-real time PCR validation of the regions shown
in (A–C). Note that H3K9me2 enrichments are already low in ES
and only slightly above background as exemplified by the active
housekeeping gene Hprt, which does not carry H3K9me2. The loss
of enrichment in neurons is small, though reproducible.
(TIF)
Figure S7 H3K9me2 in neurons rarely overlaps with promoter
regions of active genes. (A and B) Pie chart illustrating the
percentage of promoters (1 kb up- and downstream of TSS) (A)
and gene bodies (B) of transcribed genes that overlap H3K9me2-
occupied regions in neurons. Note that promoters are rarely
H3K9 dimethylated when the gene is actively transcribed.
(TIF)
Figure S8 Overlap of low-level expressed genes and expression
of transcripts per chromosome. (A) Venn diagram illustrating the
overlap of transcripts expressed at a low level (log2 RNAseq reads
between 2 and 5) in at least one of the examined cell types. Note
that areas are not drawn to scale. (B) Boxplots showing expression
levels of transcripts per chromosomes.
(TIF)
Figure S9 Absence of difference in transcriptome complexity is
not a function of sample size in next generation sequencing.
Shown is the number of detected Refseq transcripts (at least 32
reads) relative to the number of sampled reads. Number of
detected transcripts is shown as the mean of 100 rounds of
random subsampling with the same total read numbers.
Irrespective of the sample size, a random sampling of RNAseq
reads from ES cells (green line), neurons (dark green line) and
MEFs (red line) revealed a smaller number of detected transcripts
than an artificial sample with pooled reads from all three cell
types (blue line) at any given sample size.
(TIF)
Figure S10 H3K9me2 domain definition by different statistical
methods leads to similar results. (A) HMM-independent quanti-
fication of genomic coverage of H3K9me2 in ES cells and
neurons. Shown is the percentage of chromosome 19 that lies
within H3K9me2 peaks defined by a simple threshold method (t-
peaks, see Text S1). (B) Diagram illustrating the actual overlap
between regions defined to be occupied by H3K9me2 by two
different methods; a simple threshold method (t-peaks; see Text
S1) and by an HMM approach (HMM; see Text S1).
(TIF)
Table S1 List of real time PCR primers.
(TIF)
Table S2 Peptides used in dot blots in Figure S1.
(TIF)
Text S1 Supplementary methods.
(DOC)
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